Chitosan coated graphene oxide incorporated sodium alginate hydrogel beads for the controlled release of amoxicillin.

Biopolymers are crucial in pharmaceuticals, particularly for controlled drug release. In this study, we loaded the broad-spectrum antibacterial drug amoxicillin into sodium alginate, a well-known biopolymer. Graphene oxide was incorporated into the composite, and the hydrogel beads were coated with chitosan for its mucoadhesive properties. Various composites were formulated by adjusting the weight percentage of graphene oxide (GO). The fabricated beads demonstrated controlled and sustained drug release, with 98 % of the loaded drug molecules released over 24 h at gastric pH. The antibacterial test using the disc diffusion technique confirmed the drug release, exhibiting greater effectiveness against the gram-positive bacterium S. aureus than the gram-negative bacterium E. coli. The drug release data were optimized using zero order, first order, Higuchi, and Korsmeyer-Peppas models. The experimental data were best fit to the Korsmeyer-Peppas model with a relatively higher correlation coefficient value. Biocompatibility was evaluated through a cell viability test using mouse fibroblast cell lines (L929). The MTT viability assay confirmed high levels of cytocompatibility, even at higher concentrations (100 μg/mL), with 98.15 % viable cells. These results highlight the potential of the fabricated beads as an effective amoxicillin drug delivery system with biomedical applications.